Cara Therapeutics, Inc. (CARA) Social Stream



Cara Therapeutics, Inc. (CARA): $10.95

-0.33 (-2.93%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CARA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 402

in industry

Cara Therapeutics Inc (CARA) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering CARA.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 8 $35 $16 $26.125 $12.15 115.02%
2021-11-28 8 $35 $17 $26.25 $12.15 116.05%
2022-02-02 8 $35 $17.001 $26.25 $12.15 116.05%
2022-03-02 7 $35 $15 $25.875 $12.15 112.96%
2022-03-08 8 $35 $15 $26.25 $12.15 116.05%
2022-03-14 8 $33 $15 $25.5 $12.15 109.88%

The Trend in the Analyst Price Target


Over the past 27 weeks, CARA's average price target has gone down $0.83.

Over the past 48 weeks, CARA's average upside potential has been 94.13%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-09 4 47 21 35.130 29.19 20.35%
2021-05-15 4 33 17 27.630 13.20 109.32%
2021-11-09 8 35 16 26.125 18.14 44.02%
2022-03-02 7 35 15 25.875 11.53 124.41%
2022-03-08 8 35 15 26.250 11.71 124.17%

CARA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.38 6 1 1 0 0 8

The Trend in the Broker Recommendations


Over the past 90 days, CARA's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CARA as an investment opportunity.

  • In the context of all US stocks, Cara Therapeutics Inc's variance in analysts' estimates is lower than -564.56% of them.
  • To contextualize these metrics, consider that out of all US stocks, Cara Therapeutics Inc's upside potential (average analyst target price relative to current price) is greater than 634.63% of them.
  • To contextualize these metrics, consider that out of all US stocks, Cara Therapeutics Inc's average analyst price target is higher than 241.29% of them.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, Cara Therapeutics Inc's number of analysts covering the stock is higher than 729.7% of them.

Stocks similar to Cara Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CANF, CALT, and CALA.

What is the outlook for CARA? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4568 seconds.